Regeneron Pharmaceuticals
REGN
#393
Rank
$64.21 B
Marketcap
$612.50
Share price
0.42%
Change (1 day)
19.83%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $9.44 Billion USD

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are $9.44 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$9.30 B10.66%
2024-12-31$8.40 B18.27%
2023-12-31$7.10 B8.5%
2022-12-31$6.55 B-1.73%
2021-12-31$6.66 B8.6%
2020-12-31$6.13 B65.2%
2019-12-31$3.71 B24.8%
2018-12-31$2.97 B13.62%
2017-12-31$2.62 B3.8%
2016-12-31$2.52 B29.16%
2015-12-31$1.95 B51.8%
2014-12-31$1.28 B28.88%
2013-12-31$0.99 B19.62%
2012-12-31$0.83 B-0.33%
2011-12-31$0.83 B49.19%
2010-12-31$0.56 B63.05%
2009-12-31$0.34 B13.79%
2008-12-31$0.30 B-36.41%
2007-12-31$0.47 B29.18%
2006-12-31$0.36 B19.05%
2005-12-31$0.30 B6.52%
2004-12-31$0.29 B-15.02%
2003-12-31$0.34 B39.22%
2002-12-31$0.24 B7.23%
2001-12-31$0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 1,167.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$79.60 B 742.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
$83.31 B 782.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$63.52 B 572.52%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$10.83 B 14.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$4.05 B-57.08%๐Ÿ‡บ๐Ÿ‡ธ USA